Evidence map›Paper›PMID 15731333›Full record

ArticleNucleic acids research2005

Modified branched peptides with a histidine-rich tail enhance in vitro gene transfection.

Qixin Leng, A James Mixson

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in Nucleic acids research, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 79 citations in OpenAlex.

  1. Delivery of mRNA with Histidine-Lysine Peptides.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Functional peptides for siRNA delivery.Advanced drug delivery reviews · 2017
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Qixin LengDepartment of Pathology, University of Maryland Baltimore MSTF Building, 10 South Pine Street, Baltimore, MD 21201, USA.
A James Mixson
University of Maryland, Baltimore · US

Funding

Gene Delivery of P53 in a Tumor-bearing Mouse ModelR01CA096984 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI MIXSON, ARCHIBALD JAMES · 2004 to 2007
$1.1M
SYSTEMIC DELIVERY OF P53 INHIBITS BREAST CANCERR29CA070394 · NCI · UNIVERSITY OF MARYLAND BALTIMORE · PI MIXSON, ARCHIBALD JAMES · 1997 to 2001
$199k
NCI NIH HHS CA70394NCI NIH HHS CA96984NCI NIH HHS R01 CA096984
6 · The paper itself

Abstract

Successful gene therapy depends on the development of efficient, non-toxic gene delivery systems. To accomplish this objective, our laboratory has focused on solid-phase synthesized peptide carriers, in which the amino acid sequence can be varied precisely to augment intracellular DNA transport. We previously determined that linear and branched co-polymers of histidine and lysine in combination with liposomes enhanced the efficiency of gene transfection. In this study, we have modified two branched histidine-lysine (HK) peptides by adding a histidine-rich tail. In a variety of cell lines, this histidine-rich tail markedly improved transfection efficiency, presumably by increasing the buffering capacity of the polymer. One polymer with a histidine-rich tail, H2K4bT, compared favorably with the commonly used transfection agents. Together with modification of our transfection protocol, these improved HK peptides alone, without liposomes, are the effective carriers of plasmids into a variety of cells. We anticipate that branched HK peptides will continue to be developed as carriers of nucleic acids for in vitro and in vivo applications.

Indexed as

Amino Acid Sequencebeta-GalactosidaseBiopolymersCell Line, TumorCell SurvivalHistidineHumansLiposomesMolecular Sequence DataPeptidesPlasmidsTransfectionbeta-GalactosidaseBiopolymersH2K4bT proteinHistidineLiposomesPeptides

Identifiers

PMID15731333
PMCPMC549579
OpenAlexW2145562923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.